Studying the roles of PHD2 in the treatment of HCC is promising because of well-characterized hypervascular arterial feeding to HCC tumor cells.23 Our study provides evidence to suppress the expression of PHD2 in improving the survival of the patients with HCC. Here, EGLN1 is linked to hepatocellular carcinoma.